{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T22:24:33Z","timestamp":1793831073610,"version":"4.6.1"},"reference-count":107,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journalofinfection.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Infection"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.jinf.2025.106571","type":"journal-article","created":{"date-parts":[[2025,8,12]],"date-time":"2025-08-12T15:36:08Z","timestamp":1755012968000},"page":"106571","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":29,"title":["Epidemiology of resistant bacterial infections in patients with hematological malignancies or undergoing hematopoietic cell transplantation in Europe: A systematic review by the European Conference on Infections in Leukemia (ECIL)"],"prefix":"10.1016","volume":"91","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8313-7288","authenticated-orcid":false,"given":"Francesco","family":"Baccelli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuela","family":"Aguilar-Guisado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolina Garcia","family":"Vidal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5535-4602","authenticated-orcid":false,"given":"Malgorzata","family":"Mikulska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6169-1920","authenticated-orcid":false,"given":"Yuri","family":"Vanbiervliet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1801-2072","authenticated-orcid":false,"given":"Nicole","family":"Blijlevens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5706-5583","authenticated-orcid":false,"given":"Patricia","family":"Mu\u00f1oz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6970-2869","authenticated-orcid":false,"given":"Dionysios","family":"Neofytos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Cordonnier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thierry","family":"Calandra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9614-7274","authenticated-orcid":false,"given":"Dina","family":"Averbuch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6904-9473","authenticated-orcid":false,"given":"Murat","family":"Akova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.jinf.2025.106571_bib1","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1038\/s41579-024-01105-2","article-title":"Bloodstream infections: mechanisms of pathogenesis and opportunities for intervention","volume":"23","author":"Holmes","year":"2025","journal-title":"Nat Rev Microbiol"},{"issue":"1","key":"10.1016\/j.jinf.2025.106571_bib2","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.cmi.2024.09.015","article-title":"Prevention and treatment of bacterial infections in patients with haematological cancers and haematopoietic stem cell transplantation: headways and shortcomings","volume":"31","author":"Er","year":"2025","journal-title":"Clin Microbiol Infect"},{"issue":"2","key":"10.1016\/j.jinf.2025.106571_bib3","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.bbmt.2016.11.005","article-title":"Risk factors and outcomes of infections by multidrug-resistant Gram-negative bacteria in patients undergoing hematopoietic stem cell transplantation","volume":"23","author":"Patriarca","year":"2017","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jinf.2025.106571_bib4","series-title":"EBMT Handbook: Hematopoietic Cell Transplantation and Cellular Therapies","first-page":"311","article-title":"Chapter 36: Bacterial infections","author":"Averbuch","year":"2024"},{"key":"10.1016\/j.jinf.2025.106571_bib5","article-title":"Current microbiological testing approaches and documented infections at febrile neutropenia onset in patients with hematologic malignancies","volume":"147","author":"Mariana","year":"2024","journal-title":"Int J Infect Dis"},{"issue":"1","key":"10.1016\/j.jinf.2025.106571_bib6","doi-asserted-by":"crossref","first-page":"15622","DOI":"10.1038\/s41598-024-66524-w","article-title":"Impact of multidrug resistance on outcomes in hematologic cancer patients with bacterial bloodstream infections","volume":"14","author":"Park","year":"2024","journal-title":"Sci Rep"},{"issue":"3","key":"10.1016\/j.jinf.2025.106571_bib7","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1038\/s41409-019-0701-3","article-title":"Changing epidemiology of bloodstream infection in a 25-years hematopoietic stem cell transplant program: current challenges and pitfalls on empiric antibiotic treatment impacting outcomes","volume":"55","author":"Puerta-Alcalde","year":"2020","journal-title":"Bone Marrow Transplant"},{"issue":"4","key":"10.1016\/j.jinf.2025.106571_bib8","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.jinf.2013.12.006","article-title":"Aetiology and resistance in bacteraemias among adult and paediatric haematology and cancer patients","volume":"68","author":"Mikulska","year":"2014","journal-title":"J Infect"},{"issue":"11","key":"10.1016\/j.jinf.2025.106571_bib9","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1093\/cid\/cix646","article-title":"Antimicrobial resistance in Gram-negative rods causing bacteremia in hematopoietic stem cell transplant recipients: intercontinental prospective study of the infectious diseases working party of the European Bone Marrow Transplantation Group","volume":"65","author":"Averbuch","year":"2017","journal-title":"Clin Infect Dis"},{"issue":"1","key":"10.1016\/j.jinf.2025.106571_bib10","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.jinf.2017.10.009","article-title":"Fluoroquinolone prophylaxis in haematological cancer patients with neutropenia: ECIL critical appraisal of previous guidelines","volume":"76","author":"Mikulska","year":"2018","journal-title":"J Infect"},{"key":"10.1016\/j.jinf.2025.106571_bib11","unstructured":"Averbuch D, Orasch C, Cordonnier C, Livermore DM,\u00a0Mikulska M,\u00a0Viscoli\u00a0C,\u00a0et al. European guidelines for empirical antibacterial therapy for febrile neutropenic patients in the era of growing resistance: summary of the 2011 4 th European Conference on Infections in Leukemia St or ti rra ta Fo un da tio n rra ta St or ti Fo un da tio; 2011."},{"issue":"12","key":"10.1016\/j.jinf.2025.106571_bib12","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.3324\/haematol.2013.091769","article-title":"The role of antibiotic stewardship in limiting antibacterial resistance among hematology patients","volume":"98","author":"Gyssens","year":"2013","journal-title":"Haematologica"},{"key":"10.1016\/j.jinf.2025.106571_bib13","article-title":"Current practice of screening and antimicrobial prophylaxis to prevent Gram-negative bacterial infection in high-risk haematology patients: results from a pan-European survey","volume":"11","author":"Stemler","year":"2024","journal-title":"Ther Adv Infect Dis"},{"key":"10.1016\/j.jinf.2025.106571_bib14","doi-asserted-by":"crossref","first-page":"b2535","DOI":"10.1136\/bmj.b2535","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"339","author":"Moher","year":"2009","journal-title":"BMJ"},{"issue":"6","key":"10.1016\/j.jinf.2025.106571_bib15","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1080\/10428194.2023.2197532","article-title":"Impact of fluoroquinolone administration and gut mucosal colonization on the risk of pre-engraftment bloodstream infections after allogeneic hematopoietic cell transplantation","volume":"64","author":"Akhmedov","year":"2023","journal-title":"Leuk Lymphoma"},{"issue":"1","key":"10.1016\/j.jinf.2025.106571_bib16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13756-022-01198-5","article-title":"Guidance of empirical antimicrobial therapy by surveillance cultures in high-risk neutropenic patients: a retrospective cohort study","volume":"11","author":"de la Court","year":"2022","journal-title":"Antimicrob Resist Infect Control"},{"issue":"8","key":"10.1016\/j.jinf.2025.106571_bib17","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1080\/17474086.2020.1787145","article-title":"Rectal colonization with multidrug-resistant gram-negative bacteria in patients with hematological malignancies: a prospective study","volume":"13","author":"K\u00f6m\u00fcrc\u00fc","year":"2020","journal-title":"Expert Rev Hematol"},{"issue":"2","key":"10.1016\/j.jinf.2025.106571_bib18","doi-asserted-by":"crossref","first-page":"161","DOI":"10.5507\/bp.2018.047","article-title":"Ciprofloxacin prophylaxis during autologous stem cell transplantation for multiple myeloma in patients with a high rate of fluoroquinolone-resistant gram-negative bacteria colonization","volume":"163","author":"Zavrelova","year":"2019","journal-title":"Biomed Pap"},{"issue":"1","key":"10.1016\/j.jinf.2025.106571_bib19","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.bbmt.2017.08.024","article-title":"Pre-engraftment bloodstream infections after allogeneic hematopoietic cell transplantation: impact of T cell-replete transplantation from a haploidentical donor","volume":"24","author":"Mikulska","year":"2018","journal-title":"Biol Blood Marrow Transplant"},{"issue":"10","key":"10.1016\/j.jinf.2025.106571_bib20","doi-asserted-by":"crossref","first-page":"686","DOI":"10.3109\/23744235.2015.1051105","article-title":"Epidemiology and emerging resistance in bacterial bloodstream infections in patients with hematologic malignancies","volume":"47","author":"Kara","year":"2015","journal-title":"Infect Dis"},{"issue":"1","key":"10.1016\/j.jinf.2025.106571_bib21","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1111\/tid.12175","article-title":"Incidence, risk factors, and outcome of bloodstream infections during the pre-engraftment phase in 521 allogeneic hematopoietic stem cell transplantations","volume":"16","author":"Blennow","year":"2014","journal-title":"Transpl Infect Dis"},{"issue":"2","key":"10.1016\/j.jinf.2025.106571_bib22","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.ijantimicag.2012.05.001","article-title":"Characteristics of initial compared with subsequent bacterial infections among hospitalised haemato-oncological patients","volume":"40","author":"Ram","year":"2012","journal-title":"Int J Antimicrob Agents"},{"issue":"6","key":"10.1016\/j.jinf.2025.106571_bib23","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1016\/j.bbmt.2016.02.009","article-title":"Impact of gut colonization by antibiotic-resistant bacteria on the outcomes of allogeneic hematopoietic stem cell transplantation: a retrospective, single-center study","volume":"22","author":"Bilinski","year":"2016","journal-title":"Biol Blood Marrow Transplant"},{"issue":"7","key":"10.1016\/j.jinf.2025.106571_bib24","doi-asserted-by":"crossref","first-page":"2017","DOI":"10.1093\/jac\/dkac135","article-title":"Resistance to empirical \u03b2-lactams recommended in febrile neutropenia guidelines in Gram-negative bacilli bloodstream infections in Spain: a multicentre study","volume":"77","author":"Chumbita","year":"2022","journal-title":"J Antimicrob Chemother"},{"issue":"11","key":"10.1016\/j.jinf.2025.106571_bib25","doi-asserted-by":"crossref","first-page":"1884","DOI":"10.1093\/cid\/cix690","article-title":"Incidence, risk factors and outcome of pre-engraftment Gram-negative bacteremia after allogeneic and autologous hematopoietic stem cell transplantation: an Italian Prospective Multicenter Survey","volume":"65","author":"Girmenia","year":"2017","journal-title":"Clin Infect Dis"},{"issue":"12","key":"10.1016\/j.jinf.2025.106571_bib26","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1007\/s00277-016-2815-7","article-title":"Emerging resistant bacteria strains in bloodstream infections of acute leukaemia patients: results of a prospective study by the Rete Ematologica Lombarda (Rel)","volume":"95","author":"Cattaneo","year":"2016","journal-title":"Ann Hematol"},{"issue":"5","key":"10.1016\/j.jinf.2025.106571_bib27","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.jinf.2014.05.018","article-title":"Bloodstream infections in neutropenic patients with cancer: Differences between patients with haematological malignancies and solid tumours","volume":"69","author":"Marin","year":"2014","journal-title":"J Infect"},{"issue":"5","key":"10.1016\/j.jinf.2025.106571_bib28","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1111\/j.1469-0691.2012.03879.x","article-title":"Changing aetiology, clinical features, antimicrobial resistance, and outcomes of bloodstream infection in neutropenic cancer patients","volume":"19","author":"Gudiol","year":"2013","journal-title":"Clin Microbiol Infect"},{"issue":"4","key":"10.1016\/j.jinf.2025.106571_bib29","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.cmi.2014.11.022","article-title":"Current epidemiology and antimicrobial resistance data for bacterial bloodstream infections in patients with hematologic malignancies: an Italian multicentre prospective survey","volume":"21","author":"Trecarichi","year":"2015","journal-title":"Clin Microbiol Infect"},{"issue":"4","key":"10.1016\/j.jinf.2025.106571_bib30","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1128\/spectrum.00674-23","article-title":"High rate of inappropriate antibiotics in patients with hematologic malignancies and Pseudomonas aeruginosa Bacteremia following International Guideline Recommendations","volume":"11","author":"Chumbita","year":"2023","journal-title":"Microbiol Spectr"},{"issue":"4","key":"10.1016\/j.jinf.2025.106571_bib31","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.02494-19","article-title":"Clinical predictive model of multidrug resistance in neutropenic cancer patients with bloodstream infection due to Pseudomonas aeruginosa","volume":"64","author":"Gudiol","year":"2020","journal-title":"Antimicrob Agents Chemother"},{"issue":"4","key":"10.1016\/j.jinf.2025.106571_bib32","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.diagmicrobio.2017.05.003","article-title":"Pseudomonas aeruginosa bacteraemia in patients with hematologic malignancies: risk factors, treatment and outcome","volume":"88","author":"Tofas","year":"2017","journal-title":"Diagn Microbiol Infect Dis"},{"issue":"10","key":"10.1016\/j.jinf.2025.106571_bib33","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0224465","article-title":"Bloodstream infections caused by Escherichia coli in onco-haematological patients: risk factors and mortality in an Italian prospective survey","volume":"14","author":"Trecarichi","year":"2019","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.jinf.2025.106571_bib34","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.jhin.2017.11.009","article-title":"Fluoroquinolone prophylaxis in haematopoietic bone marrow transplantation: a driver for antimicrobial resistance","volume":"98","author":"Mahida","year":"2018","journal-title":"J Hosp Infect"},{"issue":"8","key":"10.1016\/j.jinf.2025.106571_bib35","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1128\/AAC.00045-21","article-title":"Impact of the inclusion of an aminoglycoside to the initial empirical antibiotic therapy for gram-negative bloodstream infections in hematological neutropenic patients: a propensity-matched cohort study (AMINOLACTAM study)","volume":"65","author":"Albasanz-Puig","year":"2021","journal-title":"Antimicrob Agents Chemother"},{"issue":"2","key":"10.1016\/j.jinf.2025.106571_bib36","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1128\/AAC.01744-21","article-title":"Impact of empirical antibiotic regimens on mortality in neutropenic patients with bloodstream infection presenting with septic shock","volume":"66","author":"Chumbita","year":"2022","journal-title":"Antimicrob Agents Chemother"},{"issue":"11","key":"10.1016\/j.jinf.2025.106571_bib37","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1002\/ajh.24489","article-title":"Bloodstream infections caused by Klebsiella pneumoniae in onco-hematological patients: clinical impact of carbapenem resistance in a multicentre prospective survey","volume":"91","author":"Trecarichi","year":"2016","journal-title":"Am J Hematol"},{"issue":"11","key":"10.1016\/j.jinf.2025.106571_bib38","doi-asserted-by":"crossref","first-page":"3146","DOI":"10.1093\/jac\/dkv218","article-title":"Mortality burden related to infection with carbapenem-resistant Gram-negative bacteria among haematological cancer patients: a retrospective cohort study","volume":"70","author":"Andria","year":"2015","journal-title":"J Antimicrob Chemother"},{"issue":"7","key":"10.1016\/j.jinf.2025.106571_bib39","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.3201\/eid2007.130094","article-title":"Carbapenemase-producing Klebsiella pneumoniae and hematologic malignancies","volume":"20","author":"Pagano","year":"2014","journal-title":"Emerg Infect Dis"},{"issue":"8","key":"10.1016\/j.jinf.2025.106571_bib40","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1007\/s00277-012-1424-3","article-title":"P. aeruginosa bloodstream infections among hematological patients: an old or new question?","volume":"91","author":"Cattaneo","year":"2012","journal-title":"Ann Hematol"},{"issue":"1","key":"10.1016\/j.jinf.2025.106571_bib41","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0210991","article-title":"Colonization with multidrug resistant organisms determines the clinical course of patients with acute myeloid leukemia undergoing intensive induction chemotherapy","volume":"14","author":"Ballo","year":"2019","journal-title":"PLoS One"},{"issue":"9","key":"10.1016\/j.jinf.2025.106571_bib42","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1016\/j.bbmt.2017.05.016","article-title":"Clinical impact of colonization with multidrug-resistant organisms on outcome after autologous stem cell transplantation: a retrospective single-center study","volume":"23","author":"Scheich","year":"2017","journal-title":"Biol Blood Marrow Transplant"},{"issue":"12","key":"10.1016\/j.jinf.2025.106571_bib43","doi-asserted-by":"crossref","first-page":"3387","DOI":"10.1093\/jac\/dku305","article-title":"A multicentre cohort study on colonization and infection with ESBL-producing Enterobacteriaceae in high-risk patients with haematological malignancies","volume":"69","author":"Vehreschild","year":"2014","journal-title":"J Antimicrob Chemother"},{"issue":"1","key":"10.1016\/j.jinf.2025.106571_bib44","doi-asserted-by":"crossref","first-page":"100","DOI":"10.5507\/bp.2014.042","article-title":"Incidence of fecal enterobacteriaceae producing broad-spectrum beta-lactamases in patients with hematological malignancies","volume":"159","author":"Kolar","year":"2015","journal-title":"Biomed Pap"},{"issue":"7","key":"10.1016\/j.jinf.2025.106571_bib45","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/j.ajic.2017.01.006","article-title":"Is surveillance for colonization of carbapenem-resistant gram-negative bacteria important in adult bone marrow transplantation units?","volume":"45","author":"Demiraslan","year":"2017","journal-title":"Am J Infect Control"},{"issue":"1","key":"10.1016\/j.jinf.2025.106571_bib46","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1186\/s12879-017-2297-9","article-title":"Carbapenem-resistant Klebsiella pneumoniae in high-risk haematological patients: factors favouring spread, risk factors and outcome of carbapenem-resistant Klebsiella pneumoniae bacteremias","volume":"17","author":"Micozzi","year":"2017","journal-title":"BMC Infect Dis"},{"issue":"2","key":"10.1016\/j.jinf.2025.106571_bib47","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1038\/bmt.2014.231","article-title":"Infections by carbapenem-resistant Klebsiella pneumoniae in SCT recipients: a nationwide retrospective survey from Italy","volume":"50","author":"Girmenia","year":"2015","journal-title":"Bone Marrow Transplant"},{"issue":"12","key":"10.1016\/j.jinf.2025.106571_bib48","doi-asserted-by":"crossref","first-page":"2501","DOI":"10.1007\/s00277-018-3475-6","article-title":"Course of colonization by multidrug-resistant organisms after allogeneic hematopoietic cell transplantation","volume":"97","author":"Heidenreich","year":"2018","journal-title":"Ann Hematol"},{"issue":"6","key":"10.1016\/j.jinf.2025.106571_bib49","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1093\/cid\/cix465","article-title":"Control of multidrug-resistant pseudomonas aeruginosa in allogeneic hematopoietic stem cell transplant recipients by a novel bundle including remodeling of sanitary and water supply systems","volume":"65","author":"Kossow","year":"2017","journal-title":"Clin Infect Dis"},{"issue":"7","key":"10.1016\/j.jinf.2025.106571_bib50","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0201169","article-title":"Stenotrophomonas maltophilia colonization during allogeneic hematopoietic stem cell transplantation is associated with impaired survival","volume":"13","author":"Scheich","year":"2018","journal-title":"PLoS One"},{"issue":"9","key":"10.1016\/j.jinf.2025.106571_bib51","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.3855\/jidc.4451","article-title":"Vancomycin-resistant enterococci colonization and bacteremia in patients with hematological malignancies","volume":"8","author":"Gedik","year":"2014","journal-title":"J Infect Dev Ctries"},{"issue":"1","key":"10.1016\/j.jinf.2025.106571_bib52","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijantimicag.2023.107043","article-title":"Prevalence of and risk factors for intestinal colonisation by multidrug-resistant Gram-negative bacteria in patients with haematological malignancies: a systematic review and meta-analysis","volume":"63","author":"Luo","year":"2024","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.jinf.2025.106571_bib53","series-title":"Antimicrobial resistance in the EU\/EEA (EARS-Net) \u2013 Annual Epidemiological Report for 2022","author":"European Centre for Disease Prevention and Control","year":"2023"},{"key":"10.1016\/j.jinf.2025.106571_bib54","series-title":"Antimicrobial resistance surveillance in Europe 2011","author":"European Centre for Disease Prevention and Control","year":"2012"},{"issue":"1","key":"10.1016\/j.jinf.2025.106571_bib55","doi-asserted-by":"crossref","first-page":"118","DOI":"10.2478\/v10039-012-0004-z","article-title":"Ciprofloxacin prophylaxis for patients undergoing high-dose chemotherapy and autologous stem cell transplantation (ASCT) \u2013 a single-center experience","volume":"57","author":"Wolska","year":"2012","journal-title":"Adv Med Sci"},{"issue":"4","key":"10.1016\/j.jinf.2025.106571_bib56","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1177\/1078155212465215","article-title":"Retrospective analysis of fluoroquinolone prophylaxis in patients undergoing allogeneic hematopoietic stem cell transplantation","volume":"19","author":"Simondsen","year":"2013","journal-title":"J Oncol Pharm Pract"},{"issue":"2","key":"10.1016\/j.jinf.2025.106571_bib57","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1007\/s00277-013-1872-4","article-title":"Incidence, risk factors, and outcome of bacteremia following autologous hematopoietic stem cell transplantation in 720 adult patients","volume":"93","author":"Pi\u00f1ana","year":"2014","journal-title":"Ann Hematol"},{"issue":"4","key":"10.1016\/j.jinf.2025.106571_bib58","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1111\/ejh.12345","article-title":"Clinical and microbiological impact of discontinuation of fluoroquinolone prophylaxis in patients with prolonged profound neutropenia","volume":"93","author":"Verlinden","year":"2014","journal-title":"Eur J Haematol"},{"issue":"3","key":"10.1016\/j.jinf.2025.106571_bib59","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1111\/ejh.13670","article-title":"Clinical and microbiological impact of long-term discontinuation of fluoroquinolone prophylaxis in haematological patients with prolonged profound neutropenia","volume":"107","author":"Verlinden","year":"2021","journal-title":"Eur J Haematol"},{"issue":"1","key":"10.1016\/j.jinf.2025.106571_bib60","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4084\/MJHID.2023.022","article-title":"Levofloxacin prophylaxis versus no prophylaxis in acute myeloid leukemia during post-induction aplasia: a single center study","volume":"15","author":"Urbino","year":"2023","journal-title":"Mediterr J Hematol Infect Dis"},{"issue":"3","key":"10.1016\/j.jinf.2025.106571_bib61","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/ph16030466","article-title":"Cost-effectiveness of targeted prophylaxis among allogenic stem cell transplant recipients","volume":"16","author":"Shbaklo","year":"2023","journal-title":"Pharmaceuticals"},{"issue":"12","key":"10.1016\/j.jinf.2025.106571_bib62","doi-asserted-by":"crossref","first-page":"2517","DOI":"10.1038\/leu.2012.124","article-title":"Oral antibiotic prophylaxis of early infection in multiple myeloma: a URCC\/ECOG randomized phase III study","volume":"26","author":"Vesole","year":"2012","journal-title":"Leukemia"},{"issue":"6","key":"10.1016\/j.jinf.2025.106571_bib63","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1111\/tid.12298","article-title":"Changing microbial epidemiology in hematopoietic stem cell transplant recipients: increasing resistance over a 9-year period","volume":"16","author":"Macesic","year":"2014","journal-title":"Transpl Infect Dis"},{"issue":"10","key":"10.1016\/j.jinf.2025.106571_bib64","doi-asserted-by":"crossref","first-page":"1808","DOI":"10.1016\/j.bbmt.2015.06.017","article-title":"Impact of prophylactic levofloxacin on rates of bloodstream infection and fever in neutropenic patients with multiple myeloma undergoing autologous hematopoietic stem cell transplantation","volume":"21","author":"Satlin","year":"2015","journal-title":"Biol Blood Marrow Transplant"},{"issue":"2","key":"10.1016\/j.jinf.2025.106571_bib65","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1177\/1078155217735153","article-title":"Impact of fluoroquinolone prophylaxis on infectious-related outcomes after hematopoietic cell transplantation","volume":"25","author":"Clemmons","year":"2019","journal-title":"J Oncol Pharm Pract"},{"issue":"7","key":"10.1016\/j.jinf.2025.106571_bib66","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1016\/j.cmi.2017.11.019","article-title":"Antibacterial prophylaxis with ciprofloxacin for patients with multiple myeloma and lymphoma undergoing autologous haematopoietic cell transplantation: a quasi-experimental single-centre before-after study","volume":"24","author":"Yeshurun","year":"2018","journal-title":"Clin Microbiol Infect"},{"issue":"2","key":"10.1016\/j.jinf.2025.106571_bib67","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.ijantimicag.2011.10.009","article-title":"Efficacy and safety of moxifloxacin as antibacterial prophylaxis for patients receiving autologous haematopoietic stem cell transplantation: a\u00a0randomised trial","volume":"39","author":"Vehreschild","year":"2012","journal-title":"Int J Antimicrob Agents"},{"issue":"3","key":"10.1016\/j.jinf.2025.106571_bib68","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/microorganisms11030742","article-title":"Bacterial bloodstream infections after allogeneic hematopoietic stem cell transplantation: etiology, risk factors and outcome in a single-center study","volume":"11","author":"Gill","year":"2023","journal-title":"Microorganisms"},{"issue":"1","key":"10.1016\/j.jinf.2025.106571_bib69","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.jinf.2017.10.009","article-title":"Fluoroquinolone prophylaxis in haematological cancer patients with neutropenia: ECIL critical appraisal of previous guidelines","volume":"76","author":"Mikulska","year":"2018","journal-title":"J Infect"},{"issue":"1","key":"10.1016\/j.jinf.2025.106571_bib70","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1080\/16078454.2019.1589706","article-title":"Efficacy of levofloxacin as an antibacterial prophylaxis for acute leukemia patients receiving intensive chemotherapy: a systematic review and meta-analysis","volume":"24","author":"Owattanapanich","year":"2019","journal-title":"Hematology"},{"issue":"10","key":"10.1016\/j.jinf.2025.106571_bib71","doi-asserted-by":"crossref","first-page":"4536","DOI":"10.1002\/cam4.2395","article-title":"Efficacy of antibiotic prophylaxis in patients with cancer and hematopoietic stem cell transplantation recipients: a systematic review of randomized trials","volume":"8","author":"Egan","year":"2019","journal-title":"Cancer Med"},{"issue":"1","key":"10.1016\/j.jinf.2025.106571_bib72","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.jinf.2014.02.013","article-title":"Antibiotic prophylaxis in hematopoietic stem cell transplantation. A meta-analysis of randomized controlled trials","volume":"69","author":"Kimura","year":"2014","journal-title":"J Infect"},{"issue":"9","key":"10.1016\/j.jinf.2025.106571_bib73","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1182\/bloodadvances.2022008226","article-title":"Levofloxacin prophylaxis vs no prophylaxis in patients with neutropenia within an endemic country for carbapenem-resistant GNB","volume":"7","author":"Clerici","year":"2023","journal-title":"Blood Adv"},{"issue":"2","key":"10.1016\/j.jinf.2025.106571_bib74","first-page":"541","article-title":"Impact of antibacterial prophylaxis during reinduction chemotherapy for relapse\/refractory acute myeloid leukemia","volume":"25","author":"Ganti","year":"2017","journal-title":"Support Care Cancer"},{"issue":"1","key":"10.1016\/j.jinf.2025.106571_bib75","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.jinf.2018.05.004","article-title":"Impact of fluoroquinolone prophylaxis during neutropenia on bloodstream infection: data from a surveillance program in 8755 patients receiving high-dose chemotherapy for haematologic malignancies between 2009 and 2014","volume":"77","author":"Kern","year":"2018","journal-title":"J Infect"},{"issue":"2","key":"10.1016\/j.jinf.2025.106571_bib76","doi-asserted-by":"crossref","DOI":"10.1111\/tid.13225","article-title":"Incidence of febrile neutropenia in autologous hematopoietic stem cell transplant (HSCT) recipients on levofloxacin prophylaxis","volume":"22","author":"Signorelli","year":"2020","journal-title":"Transpl Infect Dis"},{"issue":"12","key":"10.1016\/j.jinf.2025.106571_bib77","doi-asserted-by":"crossref","first-page":"2319","DOI":"10.1038\/s41409-020-0923-4","article-title":"Ciprofloxacin prophylaxis is associated with a lower incidence of gram-negative bacteremia in patients undergoing allogeneic hematopoietic cell transplantation","volume":"55","author":"Maurer","year":"2020","journal-title":"Bone Marrow Transplant"},{"issue":"12","key":"10.1016\/j.jinf.2025.106571_bib78","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1016\/j.clml.2022.08.001","article-title":"Impact of fluoroquinolone prophylaxis on neutropenic fever, infections, and antimicrobial resistance in newly diagnosed AML patients","volume":"22","author":"Caro","year":"2022","journal-title":"Clin Lymphoma Myeloma Leuk"},{"issue":"3","key":"10.1016\/j.jinf.2025.106571_bib79","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.bbmt.2014.12.006","article-title":"Incidence rate of fluoroquinolone-resistant Gram-negative rod bacteremia among allogeneic hematopoietic cell transplantation patients during an era of levofloxacin prophylaxis","volume":"21","author":"Miles-Jay","year":"2015","journal-title":"Biol Blood Marrow Transplant"},{"issue":"8","key":"10.1016\/j.jinf.2025.106571_bib80","doi-asserted-by":"crossref","first-page":"e198","DOI":"10.1016\/j.bbmt.2020.03.027","article-title":"Fluoroquinolone prophylaxis in autologous stem cell transplantation: worthy of a second look","volume":"26","author":"Maakaron","year":"2020","journal-title":"Biol Blood Marrow Transplant"},{"issue":"2","key":"10.1016\/j.jinf.2025.106571_bib81","doi-asserted-by":"crossref","first-page":"234","DOI":"10.20411\/pai.v1i2.115","article-title":"Increasing rates of fluoroquinolone resistance in Escherichia coli isolated from the blood and urine of patients with hematologic malignancies and stem cell transplant recipients","volume":"1","author":"Hauck","year":"2016","journal-title":"Pathog Immun"},{"issue":"2","key":"10.1016\/j.jinf.2025.106571_bib82","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1080\/10428194.2018.1488252","article-title":"Fluoroquinolone prophylaxis reduces febrile neutropenia, bloodstream infections from mucosal translocations, and intensive care admissions in high risk hematological patients, a single center experience","volume":"60","author":"Chung","year":"2019","journal-title":"Leuk Lymphoma"},{"issue":"5","key":"10.1016\/j.jinf.2025.106571_bib83","first-page":"1499","article-title":"Levofloxacin for febrile neutropenia prophylaxis in acute myeloid leukemia patients associated with reduction in hospital admissions","volume":"26","author":"Lee","year":"2018","journal-title":"Support Care Cancer"},{"issue":"12","key":"10.1016\/j.jinf.2025.106571_bib84","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.1016\/S1470-2045(19)30506-6","article-title":"Levofloxacin prophylaxis in patients with newly diagnosed myeloma (TEAMM): a multicentre, double-blind, placebo-controlled, randomised, phase 3 trial","volume":"20","author":"Drayson","year":"2019","journal-title":"Lancet Oncol"},{"issue":"12","key":"10.1016\/j.jinf.2025.106571_bib85","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1093\/cid\/ciy825","article-title":"Fluoroquinolone prophylaxis selects for meropenem-nonsusceptible Pseudomonas aeruginosa in patients with hematologic malignancies and hematopoietic cell transplant recipients","volume":"68","author":"Hakki","year":"2019","journal-title":"Clin Infect Dis"},{"issue":"3","key":"10.1016\/j.jinf.2025.106571_bib86","doi-asserted-by":"crossref","first-page":"167.e1","DOI":"10.1016\/j.jtct.2021.11.017","article-title":"Safety and efficacy of prophylactic levofloxacin in pediatric and adult hematopoietic stem cell transplantation patients","volume":"28","author":"Gardner","year":"2022","journal-title":"Transplant Cell Ther"},{"issue":"11","key":"10.1016\/j.jinf.2025.106571_bib87","doi-asserted-by":"crossref","first-page":"1790","DOI":"10.1093\/cid\/cix644","article-title":"Levofloxacin prophylaxis during induction therapy for pediatric acute lymphoblastic leukemia","volume":"65","author":"Wolf","year":"2017","journal-title":"Clin Infect Dis"},{"issue":"5","key":"10.1016\/j.jinf.2025.106571_bib88","doi-asserted-by":"crossref","first-page":"26952","DOI":"10.1002\/pbc.26952","article-title":"Effectiveness of antibacterial prophylaxis during induction chemotherapy in children with acute lymphoblastic leukemia","volume":"65","author":"Sulis","year":"2018","journal-title":"Pediatr Blood Cancer"},{"issue":"10","key":"10.1016\/j.jinf.2025.106571_bib89","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1001\/jama.2018.12512","article-title":"Effect of levofloxacin prophylaxis on Bacteremia in children with acute Leukemia or undergoing hematopoietic stem cell transplantation a randomized clinical trial","volume":"320","author":"Alexander","year":"2018","journal-title":"JAMA"},{"issue":"10","key":"10.1016\/j.jinf.2025.106571_bib90","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1001\/jama.2018.12512","article-title":"Effect of levofloxacin prophylaxis on bacteremia in children with acute leukemia or undergoing hematopoietic stem cell transplantation","volume":"320","author":"Alexander","year":"2018","journal-title":"JAMA"},{"issue":"12","key":"10.1016\/j.jinf.2025.106571_bib91","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1093\/ofid\/ofac594","article-title":"Effectiveness of quinolone prophylaxis in pediatric acute leukemia and hematopoietic stem cell transplantation: a systematic review and meta-analysis","volume":"9","author":"Leardini","year":"2022","journal-title":"Open Forum Infect Dis"},{"issue":"4","key":"10.1016\/j.jinf.2025.106571_bib92","doi-asserted-by":"crossref","first-page":"e78","DOI":"10.1097\/INF.0000000000000591","article-title":"Clinical and microbiologic outcomes of quinolone prophylaxis in children with acute myeloid leukemia","volume":"34","author":"Felsenstein","year":"2015","journal-title":"Pediatr Infect Dis J"},{"issue":"8","key":"10.1016\/j.jinf.2025.106571_bib93","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/pbc.31059","article-title":"The impact of levofloxacin prophylaxis on empiric intravenous antibiotic use in pediatric hematopoietic stem cell transplant recipients","volume":"71","author":"Prodanuk","year":"2024","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.jinf.2025.106571_bib94","doi-asserted-by":"crossref","DOI":"10.1002\/pbc.29525","article-title":"Levofloxacin prophylaxis for pediatric leukemia patients: Longitudinal follow-up for impact on health care-associated infections","volume":"69","author":"Davis","year":"2022","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.jinf.2025.106571_bib95","doi-asserted-by":"crossref","DOI":"10.1093\/cid\/ciae403","article-title":"Infectious Diseases Society of America 2024 guidance on the treatment of antimicrobial-resistant Gram-negative infections","author":"Tamma","year":"2024","journal-title":"Clin Infect Dis"},{"issue":"12","key":"10.1016\/j.jinf.2025.106571_bib96","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1093\/cid\/ciy378","article-title":"Difficult-to-treat resistance in gram-negative bacteremia at 173 US hospitals: retrospective cohort analysis of prevalence, predictors, and outcome of resistance to all first-line agents","volume":"67","author":"Kadri","year":"2018","journal-title":"Clin Infect Dis"},{"issue":"3","key":"10.1016\/j.jinf.2025.106571_bib97","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1111\/j.1469-0691.2011.03570.x","article-title":"Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance","volume":"18","author":"Magiorakos","year":"2012","journal-title":"Clin Microbiol Infect"},{"issue":"4","key":"10.1016\/j.jinf.2025.106571_bib98","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.cmi.2021.11.025","article-title":"European Society of Clinical Microbiology and Infectious Diseases (ESCMID) guidelines for the treatment of infections caused by multidrug-resistant Gram-negative bacilli (endorsed by European society of intensive care medicine)","volume":"28","author":"Paul","year":"2022","journal-title":"Clin Microbiol Infect"},{"issue":"10459","key":"10.1016\/j.jinf.2025.106571_bib99","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1016\/S0140-6736(24)01867-1","article-title":"Global burden of bacterial antimicrobial resistance 1990-2021: a systematic analysis with forecasts to 2050","volume":"404","author":"GBD 2021 Antimicrobial Resistance Collaborators","year":"2024","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.jinf.2025.106571_bib100","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1007\/s00277-024-05686-z","article-title":"Validation of a Stenotrophomonas maltophilia bloodstream infection prediction score in the hematologic malignancy population","volume":"103","author":"Gill","year":"2024","journal-title":"Ann Hematol"},{"issue":"4","key":"10.1016\/j.jinf.2025.106571_bib101","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1111\/ejh.14157","article-title":"Screening for multidrug-resistant organisms in high-risk hospitalized patients with hematologic diseases","volume":"112","author":"Delanote","year":"2024","journal-title":"Eur J Haematol"},{"issue":"4","key":"10.1016\/j.jinf.2025.106571_bib102","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1093\/cid\/ciz903","article-title":"Effect of antimicrobial stewardship on outcomes in patients with cancer or undergoing hematopoietic stem cell transplantation","volume":"71","author":"Wolf","year":"2020","journal-title":"Clin Infect Dis"},{"issue":"12","key":"10.1016\/j.jinf.2025.106571_bib103","doi-asserted-by":"crossref","first-page":"1836","DOI":"10.3324\/haematol.2013.091330","article-title":"Targeted therapy against multi-resistant bacteria in leukemic and hematopoietic stem cell transplant recipients: guidelines of the 4th European conference on Infections in Leukemia (ECIL-4, 2011)","volume":"98","author":"Averbuch","year":"2013","journal-title":"Haematologica"},{"issue":"1","key":"10.1016\/j.jinf.2025.106571_bib104","doi-asserted-by":"crossref","first-page":"13","DOI":"10.3390\/antibiotics14010013","article-title":"Development and validation of a machine learning model for the prediction of bloodstream infections in patients with hematological malignancies and febrile neutropenia","volume":"14","author":"Gallardo-Pizarro","year":"2024","journal-title":"Antibiotics"},{"key":"10.1016\/j.jinf.2025.106571_bib105","first-page":"CD004386","article-title":"Antibiotic prophylaxis for bacterial infections in afebrile neutropenic patients following chemotherapy","volume":"1","author":"Gafter-Gvili","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"issue":"3","key":"10.1016\/j.jinf.2025.106571_bib106","doi-asserted-by":"crossref","DOI":"10.3390\/jcm11030880","article-title":"Characteristics and outcomes of bloodstream infections in a tertiary-care pediatric hematology\u2013oncology unit: a 10-year study","volume":"11","author":"Mattei","year":"2022","journal-title":"J Clin Med"},{"issue":"15","key":"10.1016\/j.jinf.2025.106571_bib107","doi-asserted-by":"crossref","DOI":"10.3390\/jcm11154545","article-title":"Antimicrobial stewardship interventions in pediatric oncology: a systematic review","volume":"11","author":"Muratore","year":"2022","journal-title":"J Clin Med"}],"container-title":["Journal of Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163445325001653?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163445325001653?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,14]],"date-time":"2025-09-14T08:11:24Z","timestamp":1757837484000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0163445325001653"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":107,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,9]]}},"alternative-id":["S0163445325001653"],"URL":"https:\/\/doi.org\/10.1016\/j.jinf.2025.106571","relation":{},"ISSN":["0163-4453"],"issn-type":[{"value":"0163-4453","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Epidemiology of resistant bacterial infections in patients with hematological malignancies or undergoing hematopoietic cell transplantation in Europe: A systematic review by the European Conference on Infections in Leukemia (ECIL)","name":"articletitle","label":"Article Title"},{"value":"Journal of Infection","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jinf.2025.106571","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Ltd on behalf of The British Infection Association.","name":"copyright","label":"Copyright"}],"article-number":"106571"}}